Last month, many major news groups elected to take what should have been perceived as good news in a bad economy, and presented it as yet another slam on greedy, bloodsucking Big Pharma. Is it any wonder that most Americans express dissatisfaction with our healthcare system?
The fight over the patentability of isolated genes is misplaced since patents are usually obtained not just for the isolated gene, but also for methods of use and as part of more complex assays or kits.
In a shaky economy where demand from sponsor companies is slack, small CROs may want to consider various partnership strategies to improve stability and profitability—or be forced to liquidate. Examining current industry, economic and political trends will help CROs determine the best strategy and even thrive in the months ahead.